Patient Selection and Practical Implementation of Renal Denervation in Patients with Treatment-Resistant Hypertension
Published: 12 June 2020
More from this programme
Patients with Poor Adherence
Patients with Hypertension with High Cardiovascular Risk
Uncontrolled Hypertension despite Medication
Andrew SP Sharp
Prof Andrew Sharp is a Consultant Cardiologist at the University Hospital of Wales, Cardiff, UK. Andrew qualified from Edinburgh Medical School in 1998. He was appointed as a Consultant Cardiologist at the Royal Devon and Exeter Hospital in 2011 and Honorary Associate Professor by the University of Exeter in 2018 before moving to the University Hospital of Wales in Cardiff in the summer of 2019.
Andrew conducted his early training at the Royal Infirmary of Edinburgh, before moving to London for his senior clinical training, completing the prestigious Milan-Imperial Interventional Cardiology Fellowship programme. Dr Sharp was awarded an MD postgraduate research degree from the University of Edinburgh for his work on the hypertensive heart and his current research interests include device-based treatments for hypertension, pulmonary embolism, intracoronary imaging and coronary physiology.
Andrew's specialist interests include the pharmacological and interventional…
Dr Atul Pathak is a Pharmacologist and Cardiologist. He is leading a clinical research team focusing on cardiovascular pathophysiology and clinical pharmacology and is affiliated to INSERM (National Institute of Medical Research).
Dr Pathak has been awarded by the ESC (Young Investigator Award), by the British Pharmacological Society and the French Society of Cardiology. He is also member of the French Association of Pharmacologists, the French Society of Hypertension and Cardiology, the American Society for Heart Failure. He is elected President of the Cardiovascular Pharmacology Working Group of the French Society of Cardiology. He has both academic and institutional commitments, among them participation at advisory board at AFSSAPS (French FDA) and HAS for the review of clinical trials protocol, assessment of benefit /risk ratio of drugs (marketed or under development) and medico-economic issues (regarding lipid or blood pressure lowering drugs).
Roland E Schmieder
Professor of Internal Medicine, Nephrology and Hypertension, Head of the Clinical Research Centre and Vice Chair of the Department of Nephrology and Hypertension
Roland E Schmieder is a Professor of Internal Medicine, Nephrology and Hypertension, Head of the Clinical Research Centre and Vice Chair of the Department of Nephrology and Hypertension at the University Hospital Erlangen, Germany. He also directs the Institute of Preventative Medicine at the University Erlangen-Nuremberg and the Community Hospital Nuremberg. Roland is a member of numerous professional societies and committees, and is a Fellow of the American College of Physicians (ACP) and the American College of Cardiology (ACC). He is on the international Editorial Board of the American Journal of Hypertension, the Journal of Human Hypertension and the Journal of Nephrology, among other scientific journals. Professor Schmieder received his post-graduate medical training in nephrology, cardiology and hypertension at the University Hospital of Bonn, and then at the Alton Ochsner Foundation, New Orleans. He graduated in medicine from the…
Professor Stefano Taddei works at the Department of Medicine at the University of Pisa, Italy. He currently serves as a Fellow of the European Society of Cardiology, the European Society of Hypertension, and the International Society of Hypertension.